Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Shivakumar, Chitturi"'
Publikováno v:
Hepatology Communications, Vol 4, Iss 3, Pp 450-452 (2020)
Selective androgenic receptor modulators (SARMs) have not been approved by the U.S. Food and Drug Administration but they are heavily promoted as alternatives to androgenic anabolic steroids. We present two cases of liver injury associated with SARMs
Externí odkaz:
https://doaj.org/article/260a348165d24334b022b38e1791a894
Publikováno v:
World Journal of Hepatology
Hepatocellular carcinoma (HCC) is the most common primary liver cancer. For advanced HCC, sorafenib was considered the standard of care for more than ten years. Recently the atezolizumab and bevacizumab combination has become standard of care for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5903cafa0a6faf34f33f1a158b93fe06
https://doi.org/10.4254/wjh.v13.i9.1132
https://doi.org/10.4254/wjh.v13.i9.1132
Publikováno v:
Case Reports in Gastrointestinal Medicine, Vol 2016 (2016)
Drug-induced liver injury (DILI) with features of autoimmunity (AI) is a challenging diagnosis to make particularly due to its apparent corticosteroid responsiveness. We present the case of a 74-year-old woman who presented with a 2-week history of j
Externí odkaz:
https://doaj.org/article/ca0c9d1260ad4c14ac21bc3ac9266990
Publikováno v:
Internal Medicine Journal. 49:681-683
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c2a772a747903036ea996fe376df64
https://doi.org/10.1111/imj.14283
https://doi.org/10.1111/imj.14283
Publikováno v:
Current Gerontology and Geriatrics Research, Vol 2011 (2011)
Nonalcoholic fatty liver disease (NAFLD) is hepatic steatosis associated with metabolic abnormalities such as overweight/central obesity, insulin resistance, type 2 diabetes (T2D), and dyslipidemia. NAFLD is becoming the most common liver disease in
Externí odkaz:
https://doaj.org/article/ba917d20296f45f4b69f5e1b51654321
Autor:
Shivakumar Chitturi
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 1 (2008)
Nonalcoholic fatty liver disease comprises a range of disorders from steatosis and steatohepatitis through to cirrhosis. Nonalcoholic steatohepatitis can progress to cirrhosis and liver-related death. Therefore, managing this common disorder is becom
Externí odkaz:
https://doaj.org/article/6b32cc91c4c04e7182068dcb07ed7781
Autor:
Graham Kaye, Marie Ooi, Jennifer Truong, Narci C. Teoh, Bruce Shadbolt, Geoffrey C. Farrell, Shivakumar Chitturi
Publikováno v:
Internal Medicine Journal. 47:50-56
Background Entecavir and tenofovir potently suppress hepatitis B virus (HBV) replication so that serum HBV DNA levels 20% of cases for unclear reasons. Aim We tested whether 4-week viral load (VL) assessment could improve 96-week treatment outcome. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed174e511bffb7ec78f8db129e0f97fa
https://doi.org/10.1111/imj.13244
https://doi.org/10.1111/imj.13244
Publikováno v:
Advances in experimental medicine and biology. 1061
Overnutrition, usually with obesity and genetic predisposition, lead to insulin resistance, which is an invariable accompaniment of nonalcoholic fatty liver disease (NAFLD). The associated metabolic abnormalities, pre- or established diabetes, hypert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0effeef6bda17db78483f7879eaff9c9
https://pubmed.ncbi.nlm.nih.gov/29956204
https://pubmed.ncbi.nlm.nih.gov/29956204
Autor:
Bruce Shadbolt, Shivakumar Chitturi, Geoff Farrell, Anne Blunn, Ilys Rodriguez-Morales, Caroline To, Narci C. Teoh, Kalyana Rodrigo, Jing Yuan J Wu, Graham Kaye
Publikováno v:
Journal of Gastroenterology and Hepatology. 29:1258-1264
Background and Aim Pegylated-interferon-α/ribavirin (PEG-IFN/RBV) treatment can cure hepatitis C virus (HCV) infection but has frequent neuropsychiatric side-effects. Patients with pre-existing psychiatric illness may not be offered therapy. We esta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93eb485a02c81e88d82718c9c897663e
https://doi.org/10.1111/jgh.12515
https://doi.org/10.1111/jgh.12515
Publikováno v:
Journal of Gastroenterology and Hepatology. 29:435-441
Coffee is one of the most popular beverages in the world. Several studies consistently show that coffee drinkers with chronic liver disease have a reduced risk of cirrhosis and a lower incidence of hepatocellular carcinoma regardless of primary etiol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96f483fbe6a6cbcd12eee5c76f99a0d2
https://doi.org/10.1111/jgh.12422
https://doi.org/10.1111/jgh.12422